Tian Ruo Pu
Director/Board Member bij ONECONNECT FINANCIAL TECHNOLOGY CO., LTD.
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Jing Lou | M | 61 | 31 jaar | |
Sean Shao | M | 67 |
China Nuokang Bio-Pharmaceutical, Inc.
China Nuokang Bio-Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology China Nuokang Bio-Pharmaceutical, Inc. is a biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. It currently sells a portfolio of fourteen products, including three principal products: Baquting, its flagship bleeding control product; Aiduo, its cardiovascular stress imaging agent; and Aiwen, its anti-arrhythmic agent. The company has also entered into an exclusive agreement for the marketing and distribution in China of Kaitong, an intravenous injectable lipid emulsion of vasodilator alprostadil for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis. Its product pipeline includes four product candidates under development that address the growing market and medical needs for hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. The company was founded on November 1997 and is headquartered in Shenyang, China. | 16 jaar |
Yi Yang | F | 51 | 5 jaar | |
Chongfeng Shen | M | 54 | 3 jaar | |
Tao Wu | M | - | 8 jaar | |
Xiao Yu Li | F | 35 | 6 jaar | |
Chang Yu | M | 66 | 14 jaar | |
Hao Han Xu | M | 29 | 5 jaar | |
Zhi Jun Liang | M | - | - | |
Han Qiu | F | 49 | 8 jaar | |
Dan Zhang | M | 60 | 2 jaar | |
Jinqiu Tang | M | 41 | 5 jaar | |
Xiao Ying Gao | M | 74 |
China Nuokang Bio-Pharmaceutical, Inc.
China Nuokang Bio-Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology China Nuokang Bio-Pharmaceutical, Inc. is a biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. It currently sells a portfolio of fourteen products, including three principal products: Baquting, its flagship bleeding control product; Aiduo, its cardiovascular stress imaging agent; and Aiwen, its anti-arrhythmic agent. The company has also entered into an exclusive agreement for the marketing and distribution in China of Kaitong, an intravenous injectable lipid emulsion of vasodilator alprostadil for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis. Its product pipeline includes four product candidates under development that address the growing market and medical needs for hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. The company was founded on November 1997 and is headquartered in Shenyang, China. | 13 jaar |
Zhang Yaolin | M | 66 | 5 jaar | |
Hong Gang Tian | M | 43 | 2 jaar | |
Koon Wing Ip | M | 63 | 3 jaar | |
Quan Long | M | 54 | 3 jaar | |
Hoi Ti Yang | F | 54 | 3 jaar | |
He Yu | M | 67 | 14 jaar | |
Siu Kuen Lai | F | 48 | 7 jaar | |
Jun Ling Liu | M | 59 | 9 jaar | |
Felix Chungfai Wong | M | - |
China Nuokang Bio-Pharmaceutical, Inc.
China Nuokang Bio-Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology China Nuokang Bio-Pharmaceutical, Inc. is a biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. It currently sells a portfolio of fourteen products, including three principal products: Baquting, its flagship bleeding control product; Aiduo, its cardiovascular stress imaging agent; and Aiwen, its anti-arrhythmic agent. The company has also entered into an exclusive agreement for the marketing and distribution in China of Kaitong, an intravenous injectable lipid emulsion of vasodilator alprostadil for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis. Its product pipeline includes four product candidates under development that address the growing market and medical needs for hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. The company was founded on November 1997 and is headquartered in Shenyang, China. | 12 jaar |
Zhi Gang Zhao | M | 64 | 2 jaar | |
Bin Huang | M | 63 | 31 jaar | |
Dong Mei Su | M | 54 | 12 jaar | |
Huining Cao | M | 58 |
China Nuokang Bio-Pharmaceutical, Inc.
China Nuokang Bio-Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology China Nuokang Bio-Pharmaceutical, Inc. is a biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. It currently sells a portfolio of fourteen products, including three principal products: Baquting, its flagship bleeding control product; Aiduo, its cardiovascular stress imaging agent; and Aiwen, its anti-arrhythmic agent. The company has also entered into an exclusive agreement for the marketing and distribution in China of Kaitong, an intravenous injectable lipid emulsion of vasodilator alprostadil for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis. Its product pipeline includes four product candidates under development that address the growing market and medical needs for hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. The company was founded on November 1997 and is headquartered in Shenyang, China. | 14 jaar |
Ping Chung Choi | M | 65 | - | |
Joo Yeow Ng | M | 59 | 2 jaar | |
Wing Kin Chow | M | 73 | 4 jaar | |
Dazong Wang | M | 69 | 8 jaar | |
Bibo Xiang | M | 46 | 3 jaar | |
Yuan Yuan Ren | M | - | - | |
Xiang He | M | - | 1 jaar | |
Xin Fu | F | 45 | 2 jaar | |
Chen Xuhua | M | - | 3 jaar | |
Fan Lu | M | - | 1 jaar | |
Keke Ding | F | - | 1 jaar | |
Fei Yang | M | - | 4 jaar | |
Xingyan Gao | F | - | - | |
Amit Jindal | M | - |
Accenture AG
Accenture AG Information Technology ServicesTechnology Services Accenture AG provides services and solutions in the areas of strategy, consulting, digital, technology, and operations. The company was founded on August 5, 1983 and is headquartered in Zurich, Switzerland. | 19 jaar |
Dong Tao Luo | M | 48 | 8 jaar | |
Joseph A. Piscopo | M | - |
University of Illinois
| 29 jaar |
Yongtao Luo | M | 49 | - | |
Yan Zeng | M | 56 | 2 jaar | |
Rosalie Sagraves | M | 78 |
University of Illinois
| 29 jaar |
Wen Wei Dou | M | 58 | 7 jaar | |
Sterling Song | M | - | - | |
Yidong Hu | M | 60 | 1 jaar | |
Wen Jun Wang | F | 56 | 3 jaar | |
John Sbragia | M | - | 26 jaar | |
Xin Ma | M | 58 | - | |
Sunil Pandit | M | - | 3 jaar | |
Dong Cheng | M | 61 | 16 jaar | |
Dai Weidong | M | 64 | 9 jaar | |
Huang Yuxiang | M | 60 | - | |
Huang Runzhong | M | 51 | 5 jaar | |
Dan Xie | M | 53 | 12 jaar | |
Jiang Hong | F | - | - | |
Du Xuedong | M | 44 | 13 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Lin Cong | M | 43 | 4 jaar | |
Shiu Kau Wong | M | 66 | 6 jaar | |
Mao Dong Xu | M | 55 | 7 jaar | |
Wangchun Ye | M | 69 | 5 jaar | |
Zhi Ya Qian | F | 48 | 3 jaar | |
Feng Pan | M | 46 | - | |
Li Yun Cao | F | 54 | 5 jaar | |
Jun Lang Wang | M | - | 1 jaar | |
Min Lu | M | 63 | 5 jaar | |
Yan Kang | M | 52 | 1 jaar | |
Christian Guilliod | M | - |
University of Illinois
| 3 jaar |
Jian Liu | M | 41 | 2 jaar | |
Thomas Meier | M | 54 | 1 jaar | |
Luo Ren | M | 66 | 3 jaar | |
Duan Wang | M | 54 | 1 jaar | |
Liang Qi | M | 51 | 2 jaar | |
Yuen Chong Wai | M | 60 | 2 jaar | |
Phil Case | M | - | 5 jaar | |
Jian Hua Shao | M | - | 2 jaar | |
Yuyang Cui | M | - | - | |
Jun Ma | M | 61 | 5 jaar | |
David Chao | M | 56 | 12 jaar | |
Jian Guang Wu | M | 49 | 6 jaar | |
Sean Brynjelsen | M | 52 |
University of Illinois
| 6 jaar |
Himanshu Shah | M | 58 | 6 jaar | |
Bai Chuan Du | M | 77 | 4 jaar | |
Robert Piconi | M | 53 |
Kellogg School of Management
| 6 jaar |
Kevin D. Schneider | M | 62 | 6 jaar | |
Chit Ho | M | 49 | 3 jaar | |
Will Price | M | - |
Kellogg School of Management
| 2 jaar |
Bo Tan | M | 51 | 10 jaar | |
David Parkinson | M | 73 | 7 jaar | |
Matthew Murphy | M | - | 6 jaar | |
John P. Pascente | M | - |
University of Illinois
| 5 jaar |
Rong Chen | F | 55 | 6 jaar | |
Jin Jiang | F | - | 1 jaar | |
Peter Dobie Everingham | M | 54 | 2 jaar | |
Shane McCarthy | M | - |
Kellogg School of Management
| 3 jaar |
Pu Xing | M | 56 | 3 jaar | |
Yan Jing Jia | F | - | 5 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
China | 52 | 52.53% |
Kaaimaneilanden | 31 | 31.31% |
Verenigde Staten | 20 | 20.20% |
Zwitserland | 1 | 1.01% |
Verenigd Koninkrijk | 0 | -.--% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Tian Ruo Pu
- Persoonlijk netwerk